Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact
Biomarker Discovery & Development | Whitepapers & Reports

Merck Millipore - Expand Your Immune Checkpoint Research by Multiplexing Your Mouse Tumour Models

28 February 2023

Immune checkpoint proteins are regulators of immune activation and play a key role in maintaining immune homeostasis, preventing autoimmunity, and are involved in cancer immune escape.

Open document in a new tab

Related Events

For more on this topic, you may be interested in our upcoming Biomarkers Europe 2024

Related Resources

A New Golden Age for Target Identification: Accessing the Novel Druggable Space with Discovery Proteomics

On-demand webinar presented by Mo Jain, MD, PhD, Founder and CEO, Sapient and Jonathan Usuka, PhD, MBA Chief Business Officer, Sapient
Read More

How Multiplexing Could Increase the Availability of Blood Biomarkers for Classifying Neurodegenerative Disorders

Recent studies have used multiplex blood biomarker information from patients to distinguish individual patient subgroups for neurodegenerative diseases, helping to stratify patients by their pathology.
Read More

Lung Cancer Patient Response to Immunotherapy Could be Predicted Through AI-Calculated Biomarker 

Breakthroughs in the use of AI for biomarker prediction and validation of efficacy could shape future treatments for immunotherapies. In this case study, we look at its applications in validating lung cancer patient responses to treatment.
Read More

Related Online Activities

Join the conversation with our upcoming Monthly Science Exchanges and Webinars:
10/09/24
The Role Of Digital Biomarkers And Other Digital Technologies In The Paying The Way Forward In Patient Treatment
04/11/24
The Challenges In Integrating AI Into Biomarker Research